Tech Company Financing Transactions

GeneraMedix Pharmaceuticals Funding Round

GeneraMedix Pharmaceuticals closed a $7.5 million funding round on 9/30/2008. Investors included Ferrer Freeman & Co..

Transaction Overview

Announced On
9/30/2008
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1200 Route 22 East 2000
Bridgewater, NJ 07938
USA
Email Address
Overview
GeneraMedix Pharmaceuticals, based in Liberty Corner, New Jersey, is an international generic pharmaceutical company primarily focused on the development and sale of injectable products utilized in hospitals and specialty clinics.
Profile
GeneraMedix Pharmaceuticals LinkedIn Company Profile
Social Media
GeneraMedix Pharmaceuticals Company Twitter Account
Company News
GeneraMedix Pharmaceuticals News
Facebook
GeneraMedix Pharmaceuticals on Facebook
YouTube
GeneraMedix Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ronald Quadrel
  Ronald Quadrel LinkedIn Profile  Ronald Quadrel Twitter Account  Ronald Quadrel News  Ronald Quadrel on Facebook
Vice President
Jeff Jackowski
  Jeff Jackowski LinkedIn Profile  Jeff Jackowski Twitter Account  Jeff Jackowski News  Jeff Jackowski on Facebook
VP - Administration
Dennis Kalsow
  Dennis Kalsow LinkedIn Profile  Dennis Kalsow Twitter Account  Dennis Kalsow News  Dennis Kalsow on Facebook
VP - Finance
Dennis Potter
  Dennis Potter LinkedIn Profile  Dennis Potter Twitter Account  Dennis Potter News  Dennis Potter on Facebook
VP - General Counsel
Robin Hoke
  Robin Hoke LinkedIn Profile  Robin Hoke Twitter Account  Robin Hoke News  Robin Hoke on Facebook
VP - Operations
Christopher Zuccarelli
  Christopher Zuccarelli LinkedIn Profile  Christopher Zuccarelli Twitter Account  Christopher Zuccarelli News  Christopher Zuccarelli on Facebook
VP - R & D
Martin Joyce
  Martin Joyce LinkedIn Profile  Martin Joyce Twitter Account  Martin Joyce News  Martin Joyce on Facebook
VP - Regulatory Affairs
Vincent Andolina
  Vincent Andolina LinkedIn Profile  Vincent Andolina Twitter Account  Vincent Andolina News  Vincent Andolina on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2008: Able Planet venture capital transaction
Next: 9/30/2008: SilverCarrot venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary